State of Medtech Podcast

Trump MRI and the Truth About Longevity Scans with Sean O'Mara MD JD and Daniel J. Durand MD In this episode, Omar Khateeb sits down with @DrSeanOMara ,Founder and Senior Physician Researcher at Private Medical Research Practice, and Daniel J. Durand, Chief Medical Officer and President of @prenuvo Medical Group, to explore the growing case for preventive MRI and why early imaging is becoming one of the most important conversations in modern healthcare. Using the public debate around President Trump’s MRI as a starting point, they unpack a much larger issue: why so much serious pathology still goes undetected until it is too late, and how whole body MRI, visceral fat analysis, and early imaging may help shift medicine from reactive treatment to proactive prevention. They also discuss pancreatic cancer, fatty liver disease, visceral fat, the limits of traditional annual physicals, and why people are increasingly paying out of pocket for better visibility into their health. If you want to understand the future of preventive health, early detection, and why imaging may become a new standard for proactive care, this is a must watch. Episode Breakdown: 00:00 Introduction and Why This Conversation Matters 01:35 The MRI Debate That Sparked Everything 04:10 Why Most Diseases Are Caught Too Late 07:22 Reactive Healthcare vs Preventive Medicine 10:05 What Whole Body MRI Actually Reveals 13:18 The Truth About Annual Checkups 16:40 Why Blood Work Misses Critical Problems 19:55 Visceral Fat The Hidden Health Risk 23:20 How Fat Distribution Predicts Disease 26:45 Why Lean Does Not Mean Healthy 30:10 Fatty Liver Disease Most People Don’t Know They Have 33:40 The Link Between Obesity and Cancer Risk 36:55 Alcohol, Diet, and Real Cancer Drivers 40:05 Pancreatic Cancer Why It Is So Deadly 43:18 Why Early Detection Changes Everything 46:40 MRI vs Traditional Screening Methods 50:05 The Economics of Preventive Imaging 53:20 Why Patients Are Paying Out of Pocket 56:45 The Shift Toward Longevity Driven Healthcare 01:00:10 AI in Imaging and What It Actually Improves 01:03:25 The Limits of AI in Diagnosis 01:06:40 What Doctors Still Do Better Than Machines 01:09:55 The Future of Preventive Health Systems 01:13:20 Who Should Actually Get an MRI 01:16:05 Risks, Tradeoffs, and Overdiagnosis 01:18:10 Final Thoughts on Early Detection and Longevity Want to actually see what’s happening inside your body? Get your MRI read with $1000 off using code OMAR: growingbetternotolder.com/ultimatestart

The Book of Elon: Exploring Elon Musk’s Most Useful Ideas with Author Eric Jorgenson. In this episode, Omar Khateeb welcomes @EricJorgenson, CEO at @scribemediaco and author of The Book of Elon, for a deep conversation on ideas, authorship, and innovation. Eric discusses how he curated (@elonmusk) Elon Musk’s most important thinking into a book designed to help founders, engineers, and builders better understand first principles thinking and mission driven leadership. They also explore the evolving role of publishing, why timeless ideas deserve better curation, and how books can become intellectual assets that shape industries. For founders, creators, and thinkers interested in the intersection of entrepreneurship and writing, this episode offers valuable insight into how powerful ideas become lasting books. Episode Breakdown: 00:00 Introduction and Why Focus Matters More Than Time 01:42 The Real Problem Founders Face 04:10 First Principles Thinking Explained 07:28 How Elon Musk Approaches Problems Differently 10:52 Why Most People Work on the Wrong Things 14:20 The Power of Clarity in Decision Making 17:05 Turning Ideas Into Actionable Systems 20:12 What Separates Builders From Thinkers 23:40 Writing as a Tool for Clear Thinking 27:18 How The Book of Elon Was Created 30:05 Curating Ideas That Actually Matter 33:22 Why Most Content Lacks Depth 36:40 The Role of Mission Driven Thinking 40:15 How Great Founders Stay Focused 43:30 The Tradeoff Between Speed and Quality 47:05 Lessons From Elon Musk’s Execution Style 50:28 Why Constraints Create Better Outcomes 54:10 The Importance of Long Term Thinking 57:42 Building Products That Actually Matter 01:01:10 Advice for Founders and Builders 01:04:35 The Future of Publishing and Ideas 01:08:00 How to Think Better and Build Smarter 01:11:20 Final Thoughts and Key Takeaways

The Book of Elon: Exploring Elon Musk’s Most Useful Ideas with Author Eric Jorgenson. In this episode, Omar Khateeb welcomes @EricJorgenson, CEO at @scribemediaco and author of The Book of Elon, for a deep conversation on ideas, authorship, and innovation. Eric discusses how he curated (@elonmusk) Elon Musk’s most important thinking into a book designed to help founders, engineers, and builders better understand first principles thinking and mission driven leadership. They also explore the evolving role of publishing, why timeless ideas deserve better curation, and how books can become intellectual assets that shape industries. For founders, creators, and thinkers interested in the intersection of entrepreneurship and writing, this episode offers valuable insight into how powerful ideas become lasting books. Episode Breakdown: 00:00 Introduction and Why Focus Matters More Than Time 01:42 The Real Problem Founders Face 04:10 First Principles Thinking Explained 07:28 How Elon Musk Approaches Problems Differently 10:52 Why Most People Work on the Wrong Things 14:20 The Power of Clarity in Decision Making 17:05 Turning Ideas Into Actionable Systems 20:12 What Separates Builders From Thinkers 23:40 Writing as a Tool for Clear Thinking 27:18 How The Book of Elon Was Created 30:05 Curating Ideas That Actually Matter 33:22 Why Most Content Lacks Depth 36:40 The Role of Mission Driven Thinking 40:15 How Great Founders Stay Focused 43:30 The Tradeoff Between Speed and Quality 47:05 Lessons From Elon Musk’s Execution Style 50:28 Why Constraints Create Better Outcomes 54:10 The Importance of Long Term Thinking 57:42 Building Products That Actually Matter 01:01:10 Advice for Founders and Builders 01:04:35 The Future of Publishing and Ideas 01:08:00 How to Think Better and Build Smarter 01:11:20 Final Thoughts and Key Takeaways

MD&M Keynote: Are we innovating or iterating? $6.1B worth of advice from Ray Cohen and Tom West moderated by Omar M. Khateeb In this episode, Omar Khateeb shares a keynote discussion with Raymond W. Cohen, Chairman of the Board of Spiro Medical, and Thomas A. West, President and CEO of @NaluMed , focused on a critical question shaping the future of medtech: are we truly innovating or simply improving what already exists? The conversation examines how the industry has shifted from smaller, iterative plays to requiring larger, more capital-intensive strategies. They discuss why many startups struggle to raise funding, how venture capital firms evaluate opportunities today, and why founders must think beyond product to build a complete, investable narrative. Key insights include how to approach capital formation, the role of experienced board members in unlocking funding, and why understanding reimbursement and commercialization pathways early can determine success or failure. For founders, operators, and investors, this episode offers a clear and practical perspective on what it takes to build a meaningful and scalable medtech company today. Episode Breakdown: 00:00 Innovation vs Iteration in MedTech 00:01 Capital, Big Tech, and the Future of Healthcare 00:03 The Real Challenges in MedTech Today 00:05 Meet the Speakers and Keynote Setup 00:10 Are We Truly Innovating? 00:12 What Happens After Acquisition? 00:14 Innovation vs Iteration in Startups 00:15 What Venture Capital Really Wants 00:18 Think Bigger and Raise Bigger 00:22 Why Capital and Board Matter 00:25 The Old MedTech Playbook Is Dead 00:27 How M&A and VC Have Changed 00:30 Strategic Investors and Real Examples 00:32 Scaling with Enough Capital 00:34 The Danger of Copycat Startups 00:37 Why Founders Default to Iteration 00:39 The Power of Narrative 00:40 Manufacturing and Early Strategy 00:42 What Investors Actually Look For 00:43 Raising Big for Disruptive Ideas 00:45 Is There Really a Capital Shortage? 00:47 What Investors Bet On 00:48 Building a Winning Story 00:50 Reimbursement and Market Reality 00:53 Why Founders Fail to Convince Investors 00:55 Should You Go After Bigger Problems? 00:57 Exit Strategy and Scaling Decisions 00:59 IPO vs Acquisition 01:00 Public Market Thinking 01:02 Storytelling Drives Capital 01:03 The Reality of Building in MedTech 01:04 Big Tech vs MedTech 01:06 Pharma and New Capital Sources 01:08 Why Disruption Wins 01:09 Owning the Full Business 01:11 Building the Right Team 01:12 Everything Comes Back to Capital 01:13 No Money No Mission 01:14 The Real Impact of MedTech 01:15 Closing Thoughts

Digital Surgery, How George Murgatroyd GM & VP of Medtronic Sees AI Transforming the OR See why medical sales teams are getting more done and closing deals thanks to a proactive AI assistant named Donna. Click here to see how Donna can level up your reps askdonna.com/industry/medic… In this episode, Omar Khateeb sits down with George Murgatroyd (@gbmurg) ,General Manager and Vice President at @Medtronic , for a conversation on digital surgery, AI, and the evolution of the operating room. They explore how surgical environments are becoming more connected, how platforms like Touch Surgery are unlocking new insights into performance and workflow, and why interoperability is becoming essential for scaling innovation in healthcare. The discussion also dives into robotics, efficiency, safety, hospital adoption challenges, and what it takes to build digital platforms inside complex healthcare systems. For clinicians, MedTech leaders, founders, and investors, this episode offers a clear look at where surgical innovation is heading next. Episode Breakdown: 00:00 The Problem with Surgical Data and Learning 00:58 Introduction to OR Digitization and AI in MedTech 02:03 George Murgatroyd Background and Career Journey 04:10 Music, Creativity, and Early Career Paths 06:00 From NHS to Medtronic Digital Innovation 08:16 The Future of Healthcare and Technology Shift 10:07 Why MedTech Is Falling Behind in AI Adoption 13:28 The Real Barrier to Scaling Innovation in Healthcare 15:32 Innovation vs Iteration and Cost Challenges 19:24 Why Most MedTech Startups Fail to Scale 20:25 Can AI Reduce Healthcare Costs While Improving Quality 22:49 Platform vs Ecosystem Thinking in MedTech 26:29 Building Digital Surgery Products at Medtronic 28:53 How Surgeons Actually Learn and Improve Today 29:08 The Technology Behind Surgical Data and Insights 32:00 SaaS in MedTech and Business Model Evolution 33:34 Why Interoperability Is the Biggest Challenge in the OR 36:19 Robotics vs Digital Insights in Surgical Evolution 39:01 How Digital Systems Support Robotic Surgery Adoption 40:56 Biggest Barriers to OR Digitization 44:23 Live Streaming Surgery and Training the Next Generation 46:52 The Talent and Capital Crisis in MedTech 50:34 Ethics, Patients, and Limits of Surgical Broadcasting 53:45 How MedTech Can Attract Top Talent 56:16 Why Mission Still Matters in MedTech Careers 59:02 Apple, Innovation, and Lessons for MedTech 01:01:15 Build vs Buy vs Partner in Digital Health 01:04:40 Why Open Ecosystems Will Win in MedTech 01:06:31 Where AI Will Impact the Operating Room First 01:08:16 AI for Surgical Safety and Real-Time Decision Support 01:09:37 Will AI Guide Surgeons Like GPS 01:10:05 Why High-Volume Procedures Will Lead AI Adoption 01:12:28 Complex vs High-Volume Surgery Debate 01:15:30 Which Surgical Specialties Will Adopt AI First 01:17:24 The Next Generation of Surgeons and Digital Expectations 01:20:06 Final Thoughts and Future of MedTech 01:20:30 Music Recommendation and Closing 01:21:52 Outro and Subscribe

Digital Surgery, How George Murgatroyd GM & VP of Medtronic Sees AI Transforming the OR See why medical sales teams are getting more done and closing deals thanks to a proactive AI assistant named Donna. Click here to see how Donna can level up your reps askdonna.com/industry/medic… In this episode, Omar Khateeb sits down with George Murgatroyd (@gbmurg) ,General Manager and Vice President at @Medtronic , for a conversation on digital surgery, AI, and the evolution of the operating room. They explore how surgical environments are becoming more connected, how platforms like Touch Surgery are unlocking new insights into performance and workflow, and why interoperability is becoming essential for scaling innovation in healthcare. The discussion also dives into robotics, efficiency, safety, hospital adoption challenges, and what it takes to build digital platforms inside complex healthcare systems. For clinicians, MedTech leaders, founders, and investors, this episode offers a clear look at where surgical innovation is heading next. Episode Breakdown: 00:00 The Problem with Surgical Data and Learning 00:58 Introduction to OR Digitization and AI in MedTech 02:03 George Murgatroyd Background and Career Journey 04:10 Music, Creativity, and Early Career Paths 06:00 From NHS to Medtronic Digital Innovation 08:16 The Future of Healthcare and Technology Shift 10:07 Why MedTech Is Falling Behind in AI Adoption 13:28 The Real Barrier to Scaling Innovation in Healthcare 15:32 Innovation vs Iteration and Cost Challenges 19:24 Why Most MedTech Startups Fail to Scale 20:25 Can AI Reduce Healthcare Costs While Improving Quality 22:49 Platform vs Ecosystem Thinking in MedTech 26:29 Building Digital Surgery Products at Medtronic 28:53 How Surgeons Actually Learn and Improve Today 29:08 The Technology Behind Surgical Data and Insights 32:00 SaaS in MedTech and Business Model Evolution 33:34 Why Interoperability Is the Biggest Challenge in the OR 36:19 Robotics vs Digital Insights in Surgical Evolution 39:01 How Digital Systems Support Robotic Surgery Adoption 40:56 Biggest Barriers to OR Digitization 44:23 Live Streaming Surgery and Training the Next Generation 46:52 The Talent and Capital Crisis in MedTech 50:34 Ethics, Patients, and Limits of Surgical Broadcasting 53:45 How MedTech Can Attract Top Talent 56:16 Why Mission Still Matters in MedTech Careers 59:02 Apple, Innovation, and Lessons for MedTech 01:01:15 Build vs Buy vs Partner in Digital Health 01:04:40 Why Open Ecosystems Will Win in MedTech 01:06:31 Where AI Will Impact the Operating Room First 01:08:16 AI for Surgical Safety and Real-Time Decision Support 01:09:37 Will AI Guide Surgeons Like GPS 01:10:05 Why High-Volume Procedures Will Lead AI Adoption 01:12:28 Complex vs High-Volume Surgery Debate 01:15:30 Which Surgical Specialties Will Adopt AI First 01:17:24 The Next Generation of Surgeons and Digital Expectations 01:20:06 Final Thoughts and Future of MedTech 01:20:30 Music Recommendation and Closing 01:21:52 Outro and Subscribe

Digital Surgery, How George Murgatroyd GM & VP of Medtronic Sees AI Transforming the OR See why medical sales teams are getting more done and closing deals thanks to a proactive AI assistant named Donna. Click here to see how Donna can level up your reps askdonna.com/industry/medic… In this episode, Omar Khateeb sits down with George Murgatroyd (@gbmurg) ,General Manager and Vice President at @Medtronic , for a conversation on digital surgery, AI, and the evolution of the operating room. They explore how surgical environments are becoming more connected, how platforms like Touch Surgery are unlocking new insights into performance and workflow, and why interoperability is becoming essential for scaling innovation in healthcare. The discussion also dives into robotics, efficiency, safety, hospital adoption challenges, and what it takes to build digital platforms inside complex healthcare systems. For clinicians, MedTech leaders, founders, and investors, this episode offers a clear look at where surgical innovation is heading next. Episode Breakdown: 00:00 The Problem with Surgical Data and Learning 00:58 Introduction to OR Digitization and AI in MedTech 02:03 George Murgatroyd Background and Career Journey 04:10 Music, Creativity, and Early Career Paths 06:00 From NHS to Medtronic Digital Innovation 08:16 The Future of Healthcare and Technology Shift 10:07 Why MedTech Is Falling Behind in AI Adoption 13:28 The Real Barrier to Scaling Innovation in Healthcare 15:32 Innovation vs Iteration and Cost Challenges 19:24 Why Most MedTech Startups Fail to Scale 20:25 Can AI Reduce Healthcare Costs While Improving Quality 22:49 Platform vs Ecosystem Thinking in MedTech 26:29 Building Digital Surgery Products at Medtronic 28:53 How Surgeons Actually Learn and Improve Today 29:08 The Technology Behind Surgical Data and Insights 32:00 SaaS in MedTech and Business Model Evolution 33:34 Why Interoperability Is the Biggest Challenge in the OR 36:19 Robotics vs Digital Insights in Surgical Evolution 39:01 How Digital Systems Support Robotic Surgery Adoption 40:56 Biggest Barriers to OR Digitization 44:23 Live Streaming Surgery and Training the Next Generation 46:52 The Talent and Capital Crisis in MedTech 50:34 Ethics, Patients, and Limits of Surgical Broadcasting 53:45 How MedTech Can Attract Top Talent 56:16 Why Mission Still Matters in MedTech Careers 59:02 Apple, Innovation, and Lessons for MedTech 01:01:15 Build vs Buy vs Partner in Digital Health 01:04:40 Why Open Ecosystems Will Win in MedTech 01:06:31 Where AI Will Impact the Operating Room First 01:08:16 AI for Surgical Safety and Real-Time Decision Support 01:09:37 Will AI Guide Surgeons Like GPS 01:10:05 Why High-Volume Procedures Will Lead AI Adoption 01:12:28 Complex vs High-Volume Surgery Debate 01:15:30 Which Surgical Specialties Will Adopt AI First 01:17:24 The Next Generation of Surgeons and Digital Expectations 01:20:06 Final Thoughts and Future of MedTech 01:20:30 Music Recommendation and Closing 01:21:52 Outro and Subscribe

MD&M Keynote: Are we innovating or iterating? $6.1B worth of advice from Ray Cohen and Tom West moderated by Omar M. Khateeb In this episode, Omar Khateeb shares a keynote discussion with Raymond W. Cohen, Chairman of the Board of Spiro Medical, and Thomas A. West, President and CEO of @NaluMed , focused on a critical question shaping the future of medtech: are we truly innovating or simply improving what already exists? The conversation examines how the industry has shifted from smaller, iterative plays to requiring larger, more capital-intensive strategies. They discuss why many startups struggle to raise funding, how venture capital firms evaluate opportunities today, and why founders must think beyond product to build a complete, investable narrative. Key insights include how to approach capital formation, the role of experienced board members in unlocking funding, and why understanding reimbursement and commercialization pathways early can determine success or failure. For founders, operators, and investors, this episode offers a clear and practical perspective on what it takes to build a meaningful and scalable medtech company today. Episode Breakdown: 00:00 Innovation vs Iteration in MedTech 00:01 Capital, Big Tech, and the Future of Healthcare 00:03 The Real Challenges in MedTech Today 00:05 Meet the Speakers and Keynote Setup 00:10 Are We Truly Innovating? 00:12 What Happens After Acquisition? 00:14 Innovation vs Iteration in Startups 00:15 What Venture Capital Really Wants 00:18 Think Bigger and Raise Bigger 00:22 Why Capital and Board Matter 00:25 The Old MedTech Playbook Is Dead 00:27 How M&A and VC Have Changed 00:30 Strategic Investors and Real Examples 00:32 Scaling with Enough Capital 00:34 The Danger of Copycat Startups 00:37 Why Founders Default to Iteration 00:39 The Power of Narrative 00:40 Manufacturing and Early Strategy 00:42 What Investors Actually Look For 00:43 Raising Big for Disruptive Ideas 00:45 Is There Really a Capital Shortage? 00:47 What Investors Bet On 00:48 Building a Winning Story 00:50 Reimbursement and Market Reality 00:53 Why Founders Fail to Convince Investors 00:55 Should You Go After Bigger Problems? 00:57 Exit Strategy and Scaling Decisions 00:59 IPO vs Acquisition 01:00 Public Market Thinking 01:02 Storytelling Drives Capital 01:03 The Reality of Building in MedTech 01:04 Big Tech vs MedTech 01:06 Pharma and New Capital Sources 01:08 Why Disruption Wins 01:09 Owning the Full Business 01:11 Building the Right Team 01:12 Everything Comes Back to Capital 01:13 No Money No Mission 01:14 The Real Impact of MedTech 01:15 Closing Thoughts

Trump MRI and the Truth About Longevity Scans with Sean O'Mara MD JD and Daniel J. Durand MD In this episode, Omar Khateeb sits down with @DrSeanOMara ,Founder and Senior Physician Researcher at Private Medical Research Practice, and Daniel J. Durand, Chief Medical Officer and President of @prenuvo Medical Group, to explore the growing case for preventive MRI and why early imaging is becoming one of the most important conversations in modern healthcare. Using the public debate around President Trump’s MRI as a starting point, they unpack a much larger issue: why so much serious pathology still goes undetected until it is too late, and how whole body MRI, visceral fat analysis, and early imaging may help shift medicine from reactive treatment to proactive prevention. They also discuss pancreatic cancer, fatty liver disease, visceral fat, the limits of traditional annual physicals, and why people are increasingly paying out of pocket for better visibility into their health. If you want to understand the future of preventive health, early detection, and why imaging may become a new standard for proactive care, this is a must watch. Episode Breakdown: 00:00 Introduction and Why This Conversation Matters 01:35 The MRI Debate That Sparked Everything 04:10 Why Most Diseases Are Caught Too Late 07:22 Reactive Healthcare vs Preventive Medicine 10:05 What Whole Body MRI Actually Reveals 13:18 The Truth About Annual Checkups 16:40 Why Blood Work Misses Critical Problems 19:55 Visceral Fat The Hidden Health Risk 23:20 How Fat Distribution Predicts Disease 26:45 Why Lean Does Not Mean Healthy 30:10 Fatty Liver Disease Most People Don’t Know They Have 33:40 The Link Between Obesity and Cancer Risk 36:55 Alcohol, Diet, and Real Cancer Drivers 40:05 Pancreatic Cancer Why It Is So Deadly 43:18 Why Early Detection Changes Everything 46:40 MRI vs Traditional Screening Methods 50:05 The Economics of Preventive Imaging 53:20 Why Patients Are Paying Out of Pocket 56:45 The Shift Toward Longevity Driven Healthcare 01:00:10 AI in Imaging and What It Actually Improves 01:03:25 The Limits of AI in Diagnosis 01:06:40 What Doctors Still Do Better Than Machines 01:09:55 The Future of Preventive Health Systems 01:13:20 Who Should Actually Get an MRI 01:16:05 Risks, Tradeoffs, and Overdiagnosis 01:18:10 Final Thoughts on Early Detection and Longevity Want to actually see what’s happening inside your body? Get your MRI read with $1000 off using code OMAR: growingbetternotolder.com/ultimatestart

MD&M Keynote: Are we innovating or iterating? $6.1B worth of advice from Ray Cohen and Tom West moderated by Omar M. Khateeb In this episode, Omar Khateeb shares a keynote discussion with Raymond W. Cohen, Chairman of the Board of Spiro Medical, and Thomas A. West, President and CEO of @NaluMed , focused on a critical question shaping the future of medtech: are we truly innovating or simply improving what already exists? The conversation examines how the industry has shifted from smaller, iterative plays to requiring larger, more capital-intensive strategies. They discuss why many startups struggle to raise funding, how venture capital firms evaluate opportunities today, and why founders must think beyond product to build a complete, investable narrative. Key insights include how to approach capital formation, the role of experienced board members in unlocking funding, and why understanding reimbursement and commercialization pathways early can determine success or failure. For founders, operators, and investors, this episode offers a clear and practical perspective on what it takes to build a meaningful and scalable medtech company today. Episode Breakdown: 00:00 Innovation vs Iteration in MedTech 00:01 Capital, Big Tech, and the Future of Healthcare 00:03 The Real Challenges in MedTech Today 00:05 Meet the Speakers and Keynote Setup 00:10 Are We Truly Innovating? 00:12 What Happens After Acquisition? 00:14 Innovation vs Iteration in Startups 00:15 What Venture Capital Really Wants 00:18 Think Bigger and Raise Bigger 00:22 Why Capital and Board Matter 00:25 The Old MedTech Playbook Is Dead 00:27 How M&A and VC Have Changed 00:30 Strategic Investors and Real Examples 00:32 Scaling with Enough Capital 00:34 The Danger of Copycat Startups 00:37 Why Founders Default to Iteration 00:39 The Power of Narrative 00:40 Manufacturing and Early Strategy 00:42 What Investors Actually Look For 00:43 Raising Big for Disruptive Ideas 00:45 Is There Really a Capital Shortage? 00:47 What Investors Bet On 00:48 Building a Winning Story 00:50 Reimbursement and Market Reality 00:53 Why Founders Fail to Convince Investors 00:55 Should You Go After Bigger Problems? 00:57 Exit Strategy and Scaling Decisions 00:59 IPO vs Acquisition 01:00 Public Market Thinking 01:02 Storytelling Drives Capital 01:03 The Reality of Building in MedTech 01:04 Big Tech vs MedTech 01:06 Pharma and New Capital Sources 01:08 Why Disruption Wins 01:09 Owning the Full Business 01:11 Building the Right Team 01:12 Everything Comes Back to Capital 01:13 No Money No Mission 01:14 The Real Impact of MedTech 01:15 Closing Thoughts

How to Listen Better and Master the Subtle Art of Shutting Up. In this episode, @OmarMKhateeb , Founder of @MarketCraft_ai , explores the subtle but powerful skill of listening. While most people focus on how to speak better, persuade better, or present better, Omar explains why the true edge in communication often comes from learning when to stay quiet. He discusses why many conversations fail because people listen to reply instead of listening to understand, and how slowing down, asking better questions, and paying attention to what is not being said can completely change the quality of interactions. Omar also shares how listening plays a critical role in leadership, sales, entrepreneurship, and everyday relationships, and why the ability to truly hear others has become a rare but valuable skill in a noisy world. If you want to improve your communication, influence, and decision making, this episode offers a powerful reminder that sometimes the most impactful thing you can do is simply listen. Episode Breakdown 00:00 Introduction 00:42 Why Listening Is a Rare Skill Today 01:28 The Problem With Talking Too Much 02:12 Listening vs Waiting Your Turn to Talk 03:08 The Subtle Art of Shutting Up 04:02 Why Most People Don’t Feel Heard 04:58 Listening as a Leadership Skill 06:05 The Difference Between Hearing and Understanding 07:10 How Great Operators Use Listening 08:18 The Business Advantage of Listening First 09:27 What Happens When You Actually Let People Talk 10:34 Listening in Sales and Relationships 11:42 Why Silence Creates Better Conversations 12:48 How Listening Builds Trust Faster 13:55 The Ego Problem in Conversations 15:05 Learning to Slow Down and Observe 16:10 Practical Ways to Become a Better Listener 17:18 Why Listening Changes How People See You 19:00 Final Thoughts on the Power of Listening

How to Listen Better and Master the Subtle Art of Shutting Up. In this episode, @OmarMKhateeb , Founder of @MarketCraft_ai , explores the subtle but powerful skill of listening. While most people focus on how to speak better, persuade better, or present better, Omar explains why the true edge in communication often comes from learning when to stay quiet. He discusses why many conversations fail because people listen to reply instead of listening to understand, and how slowing down, asking better questions, and paying attention to what is not being said can completely change the quality of interactions. Omar also shares how listening plays a critical role in leadership, sales, entrepreneurship, and everyday relationships, and why the ability to truly hear others has become a rare but valuable skill in a noisy world. If you want to improve your communication, influence, and decision making, this episode offers a powerful reminder that sometimes the most impactful thing you can do is simply listen. Episode Breakdown 00:00 Introduction 00:42 Why Listening Is a Rare Skill Today 01:28 The Problem With Talking Too Much 02:12 Listening vs Waiting Your Turn to Talk 03:08 The Subtle Art of Shutting Up 04:02 Why Most People Don’t Feel Heard 04:58 Listening as a Leadership Skill 06:05 The Difference Between Hearing and Understanding 07:10 How Great Operators Use Listening 08:18 The Business Advantage of Listening First 09:27 What Happens When You Actually Let People Talk 10:34 Listening in Sales and Relationships 11:42 Why Silence Creates Better Conversations 12:48 How Listening Builds Trust Faster 13:55 The Ego Problem in Conversations 15:05 Learning to Slow Down and Observe 16:10 Practical Ways to Become a Better Listener 17:18 Why Listening Changes How People See You 19:00 Final Thoughts on the Power of Listening

This Month in MedTech: The $100B Shift Reshaping M&A, Robotics and Stroke Care In this episode, Omar Khateeb talks with Nicholas Talamantes, Sr. Director of Market Intelligence at @lsintelligence , about the biggest medtech shifts shaping Q1 2026. They cover the rise in M&A activity, why neurovascular is becoming an arms race, how robotics is shrinking to fit ASC demand, and why strategic buyers are chasing precision over scale. They also dig into commercialization, investor expectations, and what it takes for startups to prove they are building real market momentum. A sharp, data-driven look at where medtech is moving next. Episode Breakdown: 00:00 Opening Hook: MedTech Market Shift + Stroke Access Crisis 00:44 Quick Intro + Industry Context 01:05 Welcome to This Month in MedTech (LSI USA) 02:00 Why Q1 2026 Feels Like a Turning Point 03:10 M&A Surge: Boston Scientific, Medtronic, J&J Moves 04:00 Macro Snapshot: Precision Over Scale Investing 04:51 “Pragmatic Growth” Trend Explained 05:36 Funding Cycles: 2020 Boom vs Now 06:05 Early-Stage Reality Check for Founders 06:57 Commercial Validation Is Now Mandatory 08:24 Why Startups Fail (It’s Not the Product) 10:48 Investors Shift: “Who Will Actually Buy This?” 11:15 TAM vs Reality: What Actually Matters 12:23 Medtronic vs J&J Strategy Breakdown 13:38 Why Platform Strategy Is Winning 13:56 Robotics Trend: Miniaturization Era Begins 15:12 Stryker vs Think Surgical Competitive Tension 16:00 Why Smaller, Faster Robots Are Winning 17:14 Shift to ASCs (Ambulatory Surgery Centers) 18:00 Neurovascular Arms Race Begins 19:22 Stroke Market Opportunity Explained 20:32 Robotics Entering Stroke Care 21:12 Fastest Growing Category: Thrombectomy 22:20 Stroke Stats That Matter (Access Problem) 24:06 Future of Stroke Clinics + Infrastructure Play 25:34 Quantum Surgical + New Wave Deal Breakdown 26:30 Why This Acquisition Is Strategic Gold 27:36 Rise of “Mini Strategic” Companies 28:36 Oncology Robotics Competition Heating Up 30:49 Ablation Tech vs New Energy Modalities 31:21 Deal Speed Round Begins 32:02 Conformal Medical Acquisition Explained 33:22 Why M&A Momentum Matters for MedTech 33:54 VB Spine + AR Navigation Play 35:23 Why Spine Innovation Is Back 36:14 Blood Draw Automation Robot (Series V) 37:13 Consumer Health Demand Is Exploding 37:38 Embolism Tech + Mystery Strategic Investor 39:07 Speculation: Who’s Behind the Deal? 40:00 Polaris Deal + Mitral Regurgitation Market 41:09 Heart Failure: The Next Big Opportunity 42:00 Boston Scientific Goes All-In on Neuromodulation 43:16 Key Insight: Winning = Positioning, Not Product 44:31 Why 2026 Is a “Move Fast” Year 45:00 Compass AI + Data-Driven Decision Making 46:11 LSI Event Insights + Industry Direction 47:35 What This Means for the Rest of 2026 48:16 Outro + Subscribe CTA

This Month in MedTech: The $100B Shift Reshaping M&A, Robotics and Stroke Care In this episode, Omar Khateeb talks with Nicholas Talamantes, Sr. Director of Market Intelligence at @lsintelligence , about the biggest medtech shifts shaping Q1 2026. They cover the rise in M&A activity, why neurovascular is becoming an arms race, how robotics is shrinking to fit ASC demand, and why strategic buyers are chasing precision over scale. They also dig into commercialization, investor expectations, and what it takes for startups to prove they are building real market momentum. A sharp, data-driven look at where medtech is moving next. Episode Breakdown: 00:00 Opening Hook: MedTech Market Shift + Stroke Access Crisis 00:44 Quick Intro + Industry Context 01:05 Welcome to This Month in MedTech (LSI USA) 02:00 Why Q1 2026 Feels Like a Turning Point 03:10 M&A Surge: Boston Scientific, Medtronic, J&J Moves 04:00 Macro Snapshot: Precision Over Scale Investing 04:51 “Pragmatic Growth” Trend Explained 05:36 Funding Cycles: 2020 Boom vs Now 06:05 Early-Stage Reality Check for Founders 06:57 Commercial Validation Is Now Mandatory 08:24 Why Startups Fail (It’s Not the Product) 10:48 Investors Shift: “Who Will Actually Buy This?” 11:15 TAM vs Reality: What Actually Matters 12:23 Medtronic vs J&J Strategy Breakdown 13:38 Why Platform Strategy Is Winning 13:56 Robotics Trend: Miniaturization Era Begins 15:12 Stryker vs Think Surgical Competitive Tension 16:00 Why Smaller, Faster Robots Are Winning 17:14 Shift to ASCs (Ambulatory Surgery Centers) 18:00 Neurovascular Arms Race Begins 19:22 Stroke Market Opportunity Explained 20:32 Robotics Entering Stroke Care 21:12 Fastest Growing Category: Thrombectomy 22:20 Stroke Stats That Matter (Access Problem) 24:06 Future of Stroke Clinics + Infrastructure Play 25:34 Quantum Surgical + New Wave Deal Breakdown 26:30 Why This Acquisition Is Strategic Gold 27:36 Rise of “Mini Strategic” Companies 28:36 Oncology Robotics Competition Heating Up 30:49 Ablation Tech vs New Energy Modalities 31:21 Deal Speed Round Begins 32:02 Conformal Medical Acquisition Explained 33:22 Why M&A Momentum Matters for MedTech 33:54 VB Spine + AR Navigation Play 35:23 Why Spine Innovation Is Back 36:14 Blood Draw Automation Robot (Series V) 37:13 Consumer Health Demand Is Exploding 37:38 Embolism Tech + Mystery Strategic Investor 39:07 Speculation: Who’s Behind the Deal? 40:00 Polaris Deal + Mitral Regurgitation Market 41:09 Heart Failure: The Next Big Opportunity 42:00 Boston Scientific Goes All-In on Neuromodulation 43:16 Key Insight: Winning = Positioning, Not Product 44:31 Why 2026 Is a “Move Fast” Year 45:00 Compass AI + Data-Driven Decision Making 46:11 LSI Event Insights + Industry Direction 47:35 What This Means for the Rest of 2026 48:16 Outro + Subscribe CTA

Trump MRI and the Truth About Longevity Scans with Sean O'Mara MD JD and Daniel J. Durand MD In this episode, Omar Khateeb sits down with @DrSeanOMara ,Founder and Senior Physician Researcher at Private Medical Research Practice, and Daniel J. Durand, Chief Medical Officer and President of @prenuvo Medical Group, to explore the growing case for preventive MRI and why early imaging is becoming one of the most important conversations in modern healthcare. Using the public debate around President Trump’s MRI as a starting point, they unpack a much larger issue: why so much serious pathology still goes undetected until it is too late, and how whole body MRI, visceral fat analysis, and early imaging may help shift medicine from reactive treatment to proactive prevention. They also discuss pancreatic cancer, fatty liver disease, visceral fat, the limits of traditional annual physicals, and why people are increasingly paying out of pocket for better visibility into their health. If you want to understand the future of preventive health, early detection, and why imaging may become a new standard for proactive care, this is a must watch. Episode Breakdown: 00:00 Introduction and Why This Conversation Matters 01:35 The MRI Debate That Sparked Everything 04:10 Why Most Diseases Are Caught Too Late 07:22 Reactive Healthcare vs Preventive Medicine 10:05 What Whole Body MRI Actually Reveals 13:18 The Truth About Annual Checkups 16:40 Why Blood Work Misses Critical Problems 19:55 Visceral Fat The Hidden Health Risk 23:20 How Fat Distribution Predicts Disease 26:45 Why Lean Does Not Mean Healthy 30:10 Fatty Liver Disease Most People Don’t Know They Have 33:40 The Link Between Obesity and Cancer Risk 36:55 Alcohol, Diet, and Real Cancer Drivers 40:05 Pancreatic Cancer Why It Is So Deadly 43:18 Why Early Detection Changes Everything 46:40 MRI vs Traditional Screening Methods 50:05 The Economics of Preventive Imaging 53:20 Why Patients Are Paying Out of Pocket 56:45 The Shift Toward Longevity Driven Healthcare 01:00:10 AI in Imaging and What It Actually Improves 01:03:25 The Limits of AI in Diagnosis 01:06:40 What Doctors Still Do Better Than Machines 01:09:55 The Future of Preventive Health Systems 01:13:20 Who Should Actually Get an MRI 01:16:05 Risks, Tradeoffs, and Overdiagnosis 01:18:10 Final Thoughts on Early Detection and Longevity Want to actually see what’s happening inside your body? Get your MRI read with $1000 off using code OMAR: growingbetternotolder.com/ultimatestart

The Book of Elon: Exploring Elon Musk’s Most Useful Ideas with Author Eric Jorgenson. In this episode, Omar Khateeb welcomes @EricJorgenson, CEO at @scribemediaco and author of The Book of Elon, for a deep conversation on ideas, authorship, and innovation. Eric discusses how he curated (@elonmusk) Elon Musk’s most important thinking into a book designed to help founders, engineers, and builders better understand first principles thinking and mission driven leadership. They also explore the evolving role of publishing, why timeless ideas deserve better curation, and how books can become intellectual assets that shape industries. For founders, creators, and thinkers interested in the intersection of entrepreneurship and writing, this episode offers valuable insight into how powerful ideas become lasting books. Episode Breakdown: 00:00 Introduction and Why Focus Matters More Than Time 01:42 The Real Problem Founders Face 04:10 First Principles Thinking Explained 07:28 How Elon Musk Approaches Problems Differently 10:52 Why Most People Work on the Wrong Things 14:20 The Power of Clarity in Decision Making 17:05 Turning Ideas Into Actionable Systems 20:12 What Separates Builders From Thinkers 23:40 Writing as a Tool for Clear Thinking 27:18 How The Book of Elon Was Created 30:05 Curating Ideas That Actually Matter 33:22 Why Most Content Lacks Depth 36:40 The Role of Mission Driven Thinking 40:15 How Great Founders Stay Focused 43:30 The Tradeoff Between Speed and Quality 47:05 Lessons From Elon Musk’s Execution Style 50:28 Why Constraints Create Better Outcomes 54:10 The Importance of Long Term Thinking 57:42 Building Products That Actually Matter 01:01:10 Advice for Founders and Builders 01:04:35 The Future of Publishing and Ideas 01:08:00 How to Think Better and Build Smarter 01:11:20 Final Thoughts and Key Takeaways

The Book of Elon: Exploring Elon Musk’s Most Useful Ideas with Author Eric Jorgenson. In this episode, Omar Khateeb welcomes @EricJorgenson, CEO at @scribemediaco and author of The Book of Elon, for a deep conversation on ideas, authorship, and innovation. Eric discusses how he curated (@elonmusk) Elon Musk’s most important thinking into a book designed to help founders, engineers, and builders better understand first principles thinking and mission driven leadership. They also explore the evolving role of publishing, why timeless ideas deserve better curation, and how books can become intellectual assets that shape industries. For founders, creators, and thinkers interested in the intersection of entrepreneurship and writing, this episode offers valuable insight into how powerful ideas become lasting books. Episode Breakdown: 00:00 Introduction and Why Focus Matters More Than Time 01:42 The Real Problem Founders Face 04:10 First Principles Thinking Explained 07:28 How Elon Musk Approaches Problems Differently 10:52 Why Most People Work on the Wrong Things 14:20 The Power of Clarity in Decision Making 17:05 Turning Ideas Into Actionable Systems 20:12 What Separates Builders From Thinkers 23:40 Writing as a Tool for Clear Thinking 27:18 How The Book of Elon Was Created 30:05 Curating Ideas That Actually Matter 33:22 Why Most Content Lacks Depth 36:40 The Role of Mission Driven Thinking 40:15 How Great Founders Stay Focused 43:30 The Tradeoff Between Speed and Quality 47:05 Lessons From Elon Musk’s Execution Style 50:28 Why Constraints Create Better Outcomes 54:10 The Importance of Long Term Thinking 57:42 Building Products That Actually Matter 01:01:10 Advice for Founders and Builders 01:04:35 The Future of Publishing and Ideas 01:08:00 How to Think Better and Build Smarter 01:11:20 Final Thoughts and Key Takeaways

This Month in MedTech: The $100B Shift Reshaping M&A, Robotics and Stroke Care In this episode, Omar Khateeb talks with Nicholas Talamantes, Sr. Director of Market Intelligence at @lsintelligence , about the biggest medtech shifts shaping Q1 2026. They cover the rise in M&A activity, why neurovascular is becoming an arms race, how robotics is shrinking to fit ASC demand, and why strategic buyers are chasing precision over scale. They also dig into commercialization, investor expectations, and what it takes for startups to prove they are building real market momentum. A sharp, data-driven look at where medtech is moving next. Episode Breakdown: 00:00 Opening Hook: MedTech Market Shift + Stroke Access Crisis 00:44 Quick Intro + Industry Context 01:05 Welcome to This Month in MedTech (LSI USA) 02:00 Why Q1 2026 Feels Like a Turning Point 03:10 M&A Surge: Boston Scientific, Medtronic, J&J Moves 04:00 Macro Snapshot: Precision Over Scale Investing 04:51 “Pragmatic Growth” Trend Explained 05:36 Funding Cycles: 2020 Boom vs Now 06:05 Early-Stage Reality Check for Founders 06:57 Commercial Validation Is Now Mandatory 08:24 Why Startups Fail (It’s Not the Product) 10:48 Investors Shift: “Who Will Actually Buy This?” 11:15 TAM vs Reality: What Actually Matters 12:23 Medtronic vs J&J Strategy Breakdown 13:38 Why Platform Strategy Is Winning 13:56 Robotics Trend: Miniaturization Era Begins 15:12 Stryker vs Think Surgical Competitive Tension 16:00 Why Smaller, Faster Robots Are Winning 17:14 Shift to ASCs (Ambulatory Surgery Centers) 18:00 Neurovascular Arms Race Begins 19:22 Stroke Market Opportunity Explained 20:32 Robotics Entering Stroke Care 21:12 Fastest Growing Category: Thrombectomy 22:20 Stroke Stats That Matter (Access Problem) 24:06 Future of Stroke Clinics + Infrastructure Play 25:34 Quantum Surgical + New Wave Deal Breakdown 26:30 Why This Acquisition Is Strategic Gold 27:36 Rise of “Mini Strategic” Companies 28:36 Oncology Robotics Competition Heating Up 30:49 Ablation Tech vs New Energy Modalities 31:21 Deal Speed Round Begins 32:02 Conformal Medical Acquisition Explained 33:22 Why M&A Momentum Matters for MedTech 33:54 VB Spine + AR Navigation Play 35:23 Why Spine Innovation Is Back 36:14 Blood Draw Automation Robot (Series V) 37:13 Consumer Health Demand Is Exploding 37:38 Embolism Tech + Mystery Strategic Investor 39:07 Speculation: Who’s Behind the Deal? 40:00 Polaris Deal + Mitral Regurgitation Market 41:09 Heart Failure: The Next Big Opportunity 42:00 Boston Scientific Goes All-In on Neuromodulation 43:16 Key Insight: Winning = Positioning, Not Product 44:31 Why 2026 Is a “Move Fast” Year 45:00 Compass AI + Data-Driven Decision Making 46:11 LSI Event Insights + Industry Direction 47:35 What This Means for the Rest of 2026 48:16 Outro + Subscribe CTA

This Month in MedTech: The $100B Shift Reshaping M&A, Robotics and Stroke Care In this episode, Omar Khateeb talks with Nicholas Talamantes, Sr. Director of Market Intelligence at @lsintelligence , about the biggest medtech shifts shaping Q1 2026. They cover the rise in M&A activity, why neurovascular is becoming an arms race, how robotics is shrinking to fit ASC demand, and why strategic buyers are chasing precision over scale. They also dig into commercialization, investor expectations, and what it takes for startups to prove they are building real market momentum. A sharp, data-driven look at where medtech is moving next. Episode Breakdown: 00:00 Opening Hook: MedTech Market Shift + Stroke Access Crisis 00:44 Quick Intro + Industry Context 01:05 Welcome to This Month in MedTech (LSI USA) 02:00 Why Q1 2026 Feels Like a Turning Point 03:10 M&A Surge: Boston Scientific, Medtronic, J&J Moves 04:00 Macro Snapshot: Precision Over Scale Investing 04:51 “Pragmatic Growth” Trend Explained 05:36 Funding Cycles: 2020 Boom vs Now 06:05 Early-Stage Reality Check for Founders 06:57 Commercial Validation Is Now Mandatory 08:24 Why Startups Fail (It’s Not the Product) 10:48 Investors Shift: “Who Will Actually Buy This?” 11:15 TAM vs Reality: What Actually Matters 12:23 Medtronic vs J&J Strategy Breakdown 13:38 Why Platform Strategy Is Winning 13:56 Robotics Trend: Miniaturization Era Begins 15:12 Stryker vs Think Surgical Competitive Tension 16:00 Why Smaller, Faster Robots Are Winning 17:14 Shift to ASCs (Ambulatory Surgery Centers) 18:00 Neurovascular Arms Race Begins 19:22 Stroke Market Opportunity Explained 20:32 Robotics Entering Stroke Care 21:12 Fastest Growing Category: Thrombectomy 22:20 Stroke Stats That Matter (Access Problem) 24:06 Future of Stroke Clinics + Infrastructure Play 25:34 Quantum Surgical + New Wave Deal Breakdown 26:30 Why This Acquisition Is Strategic Gold 27:36 Rise of “Mini Strategic” Companies 28:36 Oncology Robotics Competition Heating Up 30:49 Ablation Tech vs New Energy Modalities 31:21 Deal Speed Round Begins 32:02 Conformal Medical Acquisition Explained 33:22 Why M&A Momentum Matters for MedTech 33:54 VB Spine + AR Navigation Play 35:23 Why Spine Innovation Is Back 36:14 Blood Draw Automation Robot (Series V) 37:13 Consumer Health Demand Is Exploding 37:38 Embolism Tech + Mystery Strategic Investor 39:07 Speculation: Who’s Behind the Deal? 40:00 Polaris Deal + Mitral Regurgitation Market 41:09 Heart Failure: The Next Big Opportunity 42:00 Boston Scientific Goes All-In on Neuromodulation 43:16 Key Insight: Winning = Positioning, Not Product 44:31 Why 2026 Is a “Move Fast” Year 45:00 Compass AI + Data-Driven Decision Making 46:11 LSI Event Insights + Industry Direction 47:35 What This Means for the Rest of 2026 48:16 Outro + Subscribe CTA

Trump MRI and the Truth About Longevity Scans with Sean O'Mara MD JD and Daniel J. Durand MD In this episode, Omar Khateeb sits down with @DrSeanOMara ,Founder and Senior Physician Researcher at Private Medical Research Practice, and Daniel J. Durand, Chief Medical Officer and President of @prenuvo Medical Group, to explore the growing case for preventive MRI and why early imaging is becoming one of the most important conversations in modern healthcare. Using the public debate around President Trump’s MRI as a starting point, they unpack a much larger issue: why so much serious pathology still goes undetected until it is too late, and how whole body MRI, visceral fat analysis, and early imaging may help shift medicine from reactive treatment to proactive prevention. They also discuss pancreatic cancer, fatty liver disease, visceral fat, the limits of traditional annual physicals, and why people are increasingly paying out of pocket for better visibility into their health. If you want to understand the future of preventive health, early detection, and why imaging may become a new standard for proactive care, this is a must watch. Episode Breakdown: 00:00 Introduction and Why This Conversation Matters 01:35 The MRI Debate That Sparked Everything 04:10 Why Most Diseases Are Caught Too Late 07:22 Reactive Healthcare vs Preventive Medicine 10:05 What Whole Body MRI Actually Reveals 13:18 The Truth About Annual Checkups 16:40 Why Blood Work Misses Critical Problems 19:55 Visceral Fat The Hidden Health Risk 23:20 How Fat Distribution Predicts Disease 26:45 Why Lean Does Not Mean Healthy 30:10 Fatty Liver Disease Most People Don’t Know They Have 33:40 The Link Between Obesity and Cancer Risk 36:55 Alcohol, Diet, and Real Cancer Drivers 40:05 Pancreatic Cancer Why It Is So Deadly 43:18 Why Early Detection Changes Everything 46:40 MRI vs Traditional Screening Methods 50:05 The Economics of Preventive Imaging 53:20 Why Patients Are Paying Out of Pocket 56:45 The Shift Toward Longevity Driven Healthcare 01:00:10 AI in Imaging and What It Actually Improves 01:03:25 The Limits of AI in Diagnosis 01:06:40 What Doctors Still Do Better Than Machines 01:09:55 The Future of Preventive Health Systems 01:13:20 Who Should Actually Get an MRI 01:16:05 Risks, Tradeoffs, and Overdiagnosis 01:18:10 Final Thoughts on Early Detection and Longevity Want to actually see what’s happening inside your body? Get your MRI read with $1000 off using code OMAR: growingbetternotolder.com/ultimatestart